OBJECTIVE: To examine the effect of age on continuation rates of reversible contraceptive methods among females aged 14-19 years and women aged 20-25 years compared with women older than 25 years of age. METHODS: We analyzed data from 7,472 participants enrolled in the Contraceptive CHOICE Project, a prospective cohort study of women offered no-cost contraception. Our primary objective was to compare 12-month continuation rates between females aged 14-19, 20-25, and 26 years and older. We collected data about method continuation from telephone surveys and chart review. We used Kaplan-Meier survival curves to estimate continuation and Cox proportional hazard models to examine the risk of contraceptive method discontinuation. RESULTS: Twelve-month continuation of long-acting reversible contraceptive (LARC) methods was more than 75% for all age groups. Females aged 14-19 years using LARC methods had slightly lower continuation rates (81%) than older women (85-86%), but this did not reach statistical or clinical significance. Compared with women older than 25 years of age, females aged 14-19 years had higher discontinuation rates for non-LARC methods (53% compared with 44%; adjusted hazard ratio 1.32, 95% confidence interval [CI] 1.02-1.73). The females aged 14-19 years were less likely to be satisfied with non-LARC methods (42% compared with 51%; adjusted relative risk 0.80, 95% CI 0.65-0.98), but not with LARC methods (75% compared with 83%; relative risk 0.94, 95% CI 0.88-1.01) when compared with women older than 25 years of age; however, the differences were small. CONCLUSION: Teenagers and young women have high rates of LARC method continuation.
OBJECTIVE: To examine the effect of age on continuation rates of reversible contraceptive methods among females aged 14-19 years and women aged 20-25 years compared with women older than 25 years of age. METHODS: We analyzed data from 7,472 participants enrolled in the Contraceptive CHOICE Project, a prospective cohort study of women offered no-cost contraception. Our primary objective was to compare 12-month continuation rates between females aged 14-19, 20-25, and 26 years and older. We collected data about method continuation from telephone surveys and chart review. We used Kaplan-Meier survival curves to estimate continuation and Cox proportional hazard models to examine the risk of contraceptive method discontinuation. RESULTS: Twelve-month continuation of long-acting reversible contraceptive (LARC) methods was more than 75% for all age groups. Females aged 14-19 years using LARC methods had slightly lower continuation rates (81%) than older women (85-86%), but this did not reach statistical or clinical significance. Compared with women older than 25 years of age, females aged 14-19 years had higher discontinuation rates for non-LARC methods (53% compared with 44%; adjusted hazard ratio 1.32, 95% confidence interval [CI] 1.02-1.73). The females aged 14-19 years were less likely to be satisfied with non-LARC methods (42% compared with 51%; adjusted relative risk 0.80, 95% CI 0.65-0.98), but not with LARC methods (75% compared with 83%; relative risk 0.94, 95% CI 0.88-1.01) when compared with women older than 25 years of age; however, the differences were small. CONCLUSION: Teenagers and young women have high rates of LARC method continuation.
Authors: Iñaki Lete; Ezequiel Pérez-Campos; Marta Correa; Javier Robledo; Esther de la Viuda; Teresa Martínez; Nicolás Mendoza; Nuria Parera; José V González; María A Gómez; Camil Castelo-Branco; Paloma Lobo Journal: J Womens Health (Larchmt) Date: 2011-10-26 Impact factor: 2.681
Authors: Tina R Raine; Anne Foster-Rosales; Ushma D Upadhyay; Cherrie B Boyer; Beth A Brown; Abby Sokoloff; Cynthia C Harper Journal: Obstet Gynecol Date: 2011-02 Impact factor: 7.661
Authors: Britt Lunde; Lisa Littman; Samantha Stimmel; Rima Rana; Adam Jacobs; Carol R Horowitz Journal: J Pediatr Adolesc Gynecol Date: 2017-01-06 Impact factor: 1.814
Authors: Uche F Onyewuchi; Kathy Tomaszewski; Krishna K Upadhya; Priya S Gupta; Natalie Whaley; Anne E Burke; Maria E Trent Journal: Clin Pediatr (Phila) Date: 2018-10-13 Impact factor: 1.168
Authors: Gina M Secura; Tessa Madden; Colleen McNicholas; Jennifer Mullersman; Christina M Buckel; Qiuhong Zhao; Jeffrey F Peipert Journal: N Engl J Med Date: 2014-10-02 Impact factor: 91.245
Authors: Elizabeth O Schmidt; Aimee James; K Michele Curran; Jeffrey F Peipert; Tessa Madden Journal: J Adolesc Health Date: 2015-06-27 Impact factor: 5.012